Evidence map›Paper›PMID 27328847›Full record

ReviewHepatology international2016

Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

G Liamis, T D Filippatos, A Liontos, M S Elisaf

Abstract readReview
PubMed Publisher
In one paragraph

Review in Hepatology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Evidence-based hyponatremia management in liver disease.Clinical and molecular hepatology · 2023
    Review
  5. Review
  6. Review
  7. Evaluation of the Prognostic Value of Existing Scoring Systems for Nosocomial Infection in Patients with Decompensated Liver Cirrhosis.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  8. Hyponatremia in Patients with Hematologic Diseases.Journal of clinical medicine · 2020
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Hyponatremia in the elderly: challenges and solutions.Clinical interventions in aging · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

G LiamisDepartment of Internal Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina, Greece.
T D FilippatosDepartment of Internal Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina, Greece. filtheo@gmail.com.
A LiontosDepartment of Internal Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina, Greece.
M S ElisafDepartment of Internal Medicine, School of Medicine, University of Ioannina, 451 10, Ioannina, Greece.
University of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyponatremia (Na(+) <135 mmol/l) is the most common electrolyte disorder. Cirrhosis represents a rather frequent cause of hyponatremia mainly due to systemic and splanchnic vasodilation resulting in decreased effective arterial blood volume, which leads to excessive non-osmotic secretion of antidiuretic hormone. However, hyponatremia of multifactorial origin may be seen in patients with liver diseases. The review focuses on the factors and pathogenetic mechanisms of decreased sodium levels other than the hemodynamic compromise of cirrhosis in patients with liver diseases. The mechanisms and causal or contributing role of pseudohyponatremia, hyperglycemia, infections, drugs and toxins as well as of endocrine disorders, renal failure and cardiac disease in patients with liver disease are meticulously discussed. Hyponatremia of multifactorial origin is frequently observed in patients with liver diseases, and special efforts should be made to delineate the underlying causative and precipitating factors as well as the risk factors of the osmotic demyelination syndrome in order to properly manage this serious electrolyte disorder and avoid treatment pitfalls.

Indexed as

HumansHyponatremiaLiver DiseasesRisk FactorsCirrhosisHepatitisHyponatremiaInfectionLiver diseaseTerlipressin

Identifiers

PMID27328847
OpenAlexW2464808874

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.